A new daily pill could provide an easier, more convenient way to lower cholesterol and reduce heart attack and stroke risk.The experimental medication, called Obicetrapib, underwent a Phase 3 clinical trial at Monash University in Australia.The trial included more than 2,500 people averaging 65 years of age. All had either been diagnosed with heart disease or had genetically high cholesterol, according to a university press release.THIS CHEAP PANTRY STAPLE COULD BE KEY TO LOWERING CHOLESTEROL, NEW RESEARCH SUGGESTSAll participants were receiving "maximum tolerated doses" of cholesterol-lowering therapy.One group received Obicetrapib and another group took a placebo, while still maintaining their existing cholesterol drugs.After 12 weeks, the participants taking the new drug showed a 32.6% reduction in LDL cholesterol and a 33.5% drop in lipoprotein(a) [Lp(a)], the release stated.The findings were presented last month at the European Atherosclerosis Society Congress in the U.K. and were also published in The New England Journal of Medicine.WOMENS HEART DISEASE RISK COULD BE PREDICTED UP TO 30 YEARS IN ADVANCE WITH ONE BLOOD TEST, STUDY FINDS"We know that many people at high risk of heart attack or stroke dont get their cholesterol levels low enough, even on the best available treatments," said study lead Professor Stephen Nicholls, director of Monash Universitys Victorian Heart Institute and Monash Healths Victorian Heart Hospital, in the release."Obicetrapib offers a promising new option not only did it lower LDL cholesterol by over 30%, but we also saw a reduction in Lp(a), which is much harder to treat and has been linked to increased heart disease risk."Low-density lipoprotein (LDL), which is sometimes called "bad cholesterol," is associated with negative health effects when present in high amounts.LDL can build up in the blood vessels and increase heart attack and stroke risk, the researchers cautioned.Lipoprotein(a), or Lp(a), is a protein that is known to greatly increase thechances of a heart attack when its present in high levels in the blood.Unlike LDL, Lp(a) is an inherited risk factor that cant be modified with healthy behaviors or medications.Obicetrapib was found to be "well-tolerated" by the participants, the researchers noted."This could be a valuable tool in the fight against heart disease," Nicholls added. "Its convenient, its effective, and it may help close the gap for patients whove run out of options."CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTERThe study which was funded by NewAmsterdam Pharma, a developer of Obicetrapib that is based in the Netherlands did have some limitations, the researchers noted.For example, the participants were not chosen based on high Lp(a), which means the study did not determine how the drug impacted those with elevated levels of the protein.Additionally, the study assessed changes in LDL levels, but did not measure actual heart attack or stroke outcomes.For more Health articles, visitwww.foxnews.com/healthMore studies are needed to follow patients for longer time periods and to include more diverse cohorts, the researchers acknowledged.Fox News Digital reached out to the researchers for additional comment.

Chicago Sky star Angel Reese secured the first triple-double of her career on Sunday against the Connecticut Sun, but it didnt come without a heated moment during their matchup.In the third quarter, Reese and Sun guard Bria Hartley were vying for a rebound. Reese was grabbed as she tried to reach for the ball and she didnt like how Hartley played her for the board. Connecticut forward Olivia Nelson-Ododa stepped in between the two players, and Reese responded with a shove.CLICK HERE FOR MORE SPORTS COVERAGE ON FOXNEWS.COMA different angle of the moment showed Hartley grabbing Reeses hair as the Sky player went up for the rebound.Sun veteran Tina Charles was also involved in the skirmish as she had words for the second-year player. Reese seemed to signal to Charles that her hair was pulled.Reese and Charles were hit with technical fouls.ANGEL REESE'S TEAMMATE DEMANDS 'RESPECT' FOR EMOTIONAL STAR IN RESPONSE TO ONLINE SCRUTINYChicago eventually pulled away from Connecticut and won the game 78-66. Reese had 11 points, 13 rebounds and 11 assists in the Skys third win of the season. She was two-of-seven from the field and made all seven of her free-throw attempts.Sky rookie Hailey Van Lith had 16 points all the bench, leading all Chicago scorers.Connecticut dropped to 2-8 on the year. Marina Mabrey led the team with 22 points and five rebounds. Charles added 19 points and six rebounds.Follow Fox News Digitalssports coverage on X, and subscribe to the Fox News Sports Huddle newsletter.

Experimental cholesterol pill cuts heart attack risk with 'convenient' once-daily dose NEWYou can now listen to Fox News articles! A new daily pill could provide an easier, more convenient way to lower cholesterol and reduce heart attack and stroke risk.The experimental medication, called Obicetrapib, underwent a Phase 3 clinical trial at Monash University in Australia.The trial included more...

Intermittent fasting's surprising biblical roots revealed as diet trend grows NEWYou can now listen to Fox News articles! A popular diet trend may have its origins in the Bible.Intermittent fasting, a pattern of eating based on time limits, is intended to assist with weight loss and other health benefits, according to Mayo Clinic.There are several types of intermittent fasting, but they all...

Why strategists are boosting their S&P 500 year-end targets Sun, Jun 15, 2025, 8:00 AM In This Article: Several Wall Street analysts are turning bullish on US stocks, boosting their year-end targets for the S&P 500 (^GSPC). Keith Lerner, Truist co–chief investment officer and chief market strategist, joins Morning Brief with Madison Mills and Brad Smith to explain why he,...